BackHLS Therapeutics Overview

HLS Therapeutics Current Assets

Track HLS Therapeutics's current assets ($31M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$30.51M
↑ 1.58% YoYΔ $476000.00 vs prior year quarter

Peer trimmed avg / median

Loading

HLS Therapeutics Current Assets History

Loading

HLS Therapeutics vs. peers: Current Assets Comparison

Loading

HLS Therapeutics Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

HLS Therapeutics (HLTRF) FAQ

HLS Therapeutics posts a current assets of $31M as of June 2026. That compares with $30M in the prior-year period — up 1.6% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, HLS Therapeutics's current assets was $30M. The latest reading is $31M — a 1.6% year-over-year increase (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Current Assets is one piece of HLS Therapeutics's financial statement story. At $31M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for HLTRF's current assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; HLS Therapeutics's other metric pages and overview cover the third.